Literature DB >> 5430418

Estimation of prothrombin in liver disease.

P M Mannucci.   

Abstract

Prothrombin, both by a one- and a two-stage method, and progressive antithrombin were determined on the same plasma samples from 47 patients with cirrhosis and 27 patients with acute hepatitis. In the first group prothrombin estimated by the two-stage method was significantly higher than by the one-stage method. The values were often within the normal range and were not correlated with the indices of protein synthesis. Since progressive antithrombin was also depressed, the unduly high levels measured by the two-stage method are probably related to the influence exerted by antithrombin on the two-stage method. The opposite pattern was observed in patients with acute hepatitis, ie, the one-stage assay gave higher values than the two-stage assay. The one-stage method correlated better with the indices of protein synthesis. It is suggested that a one-stage assay should be used in patients with liver failure to evaluate the haemostatic balance before liver biopsy or surgery.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5430418      PMCID: PMC476745          DOI: 10.1136/jcp.23.4.291

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  Plasma prothrombin in liver disease: its clinical and prognostic significance.

Authors:  G MINDRUM; H I GLUECK
Journal:  Ann Intern Med       Date:  1959-06       Impact factor: 25.391

2.  Congenital afibrinogenaemia; further observations on the blood coagulation mechanism.

Authors:  R M HARDISTY; J L PINNIGER
Journal:  Br J Haematol       Date:  1956-04       Impact factor: 6.998

3.  Coagulation defects in liver disease.

Authors:  D C COWLING
Journal:  J Clin Pathol       Date:  1956-11       Impact factor: 3.411

4.  [Behavior of antithrombic substances in liver diseases].

Authors:  J JURGENS
Journal:  Dtsch Arch Klin Med       Date:  1952

5.  [Evaluation of liver function by determination of factor V, factor VII and prothrombin; effects of synkavit and vitamin K1].

Authors:  M M FORELL; F KOLLER
Journal:  Munch Med Wochenschr       Date:  1953-04-10

6.  Prothrombin and haemorrhage.

Authors:  A C DONALD; R B HUNTER; G R TUDHOPE; W WALKER; I WHITTON
Journal:  Br Med J       Date:  1954-10-23

7.  The plasma antithrombin titer in incipient and advanced liver failure.

Authors:  I INNERFIELD; A ANGRIST; L J BOYD
Journal:  Gastroenterology       Date:  1952-03       Impact factor: 22.682

8.  Antithrombin 3 and diseases.

Authors:  E Von Kaulla; K N Von Kaulla
Journal:  Am J Clin Pathol       Date:  1967-07       Impact factor: 2.493

9.  Coagulation factors in chronic liver disease.

Authors:  G W Donaldson; S H Davies; A Darg; J Richmond
Journal:  J Clin Pathol       Date:  1969-03       Impact factor: 3.411

10.  Coagulant activity of tiger snake (Notechis scutatus scutatus) venom.

Authors:  F Jobin; M P Esnouf
Journal:  Nature       Date:  1966-08-20       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.